NuVasive, Inc. - Common Stock (NQ:NUVA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 31, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NuVasive, Inc. - Common Stock

< Previous 1 2 3 Next >

Expert Ratings for NuVasive ↗

August 04, 2023

Via Benzinga

NuVasive Earnings Preview ↗

August 01, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About NuVasive ↗

May 31, 2023

Via Benzinga

The Latest Analyst Ratings for NuVasive ↗

May 31, 2023

Via Benzinga

Expert Ratings for NuVasive ↗

May 12, 2023

Via Benzinga

Recap: NuVasive Q1 Earnings ↗

May 10, 2023

Via Benzinga

NuVasive's Earnings: A Preview ↗

May 09, 2023

Via Benzinga

Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive

April 27, 2023

From Globus Medical

Via GlobeNewswire

Where NuVasive Stands With Analysts ↗

January 06, 2023

Via Benzinga

Looking Into NuVasive's Return On Invested Capital ↗

December 12, 2022

Via Benzinga

What 11 Analyst Ratings Have To Say About NuVasive ↗

November 10, 2022

Analysts have provided the following ratings for NuVasive (NASDAQ:NUVA) within the last quarter:

Via Benzinga

NUVASIVE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NuVasive, Inc. - NUVA

March 29, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)

February 22, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

February 14, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Earnings Scheduled For February 22, 2023 ↗

February 22, 2023

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.

Via Benzinga

Where NuVasive Stands With Analysts ↗

November 10, 2022

NuVasive (NASDAQ:NUVA) has observed the following analyst ratings within the last quarter:

Via Benzinga

Where NuVasive Stands With Analysts ↗

October 07, 2022

Within the last quarter, NuVasive (NASDAQ:NUVA) has observed the following analyst ratings:

Via Benzinga

NUVASIVE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NuVasive, Inc. - NUVA

February 13, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2023 ↗

February 10, 2023

Via Benzinga

Micron Technology To Rally 20%? Here Are 10 Other Analyst Forecasts For Friday ↗

February 10, 2023

Mizuho boosted the price target for Micron Technology, Inc. (NASDAQ: MU) from $48 to $72. Mizuho analyst Vijay Rakesh upgraded the stock from Neutral to Buy. Micron shares fell 0.3% to $59.99 in...

Via Benzinga

February 09, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Globus Medical-NuVasive Deal To Accelerate Globalization Strategy, Target $50B Musculoskeletal Market ↗

February 09, 2023

Via Benzinga

NUVA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NuVasive, Inc. Is Fair to Shareholders

February 09, 2023

From Halper Sadeh LLC

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 09, 2023

We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday!

Via InvestorPlace

Allegro Microsystems, CubeSmart To Join S&P MidCap 400; ALGM Stock Set To Break Out ↗

December 04, 2022

Allegro Microsystems and CubeSmart will join the S&P MidCap 400.

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Thursday ↗

November 10, 2022

During Thursday's session, 97 companies made new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 ↗

January 06, 2023

Via Benzinga

Bristol-Myers Squibb To Surge Over 10%? Plus Morgan Stanley Predicts $263 For L3Harris Technologies ↗

November 10, 2022

Atlantic Equities boosted the price target on Bristol-Myers Squibb Company (NYSE: BMY) from $85 to $88. Atlantic Equities analyst Steve Chesney maintained the stock with an Overweight. Bristol-Myers...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022 ↗

October 18, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗

October 12, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.